• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Memantine Hydrochloride (Namenda) XR Capsules

 Status: Currently in Shortage

 » Date first reported: 08/06/2014
 » Therapeutic Categories: Neurology

Forest Laboratories, Inc. (Reverified 10/14/2014)

Company Contact Information:
800-678-1605 EXT. 66298

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Namenda XR 14 mg Bottle of 30 (NDC 0456-3414-33) Product currently available in limited supply; estimated duration 4-6 months Manufacturing delay based upon commercial stability data and the discontinuation of blister packaging. Other
Namenda XR 14 mg Bottle of 90 (NDC 0456-3414-90) Product currently unavailable; estimated duration 6-12 months Manufacturing delay based upon commercial stability data and the discontinuation of blister packaging. Other
Namenda XR 14 mg 10 x 10 Unit Dose: (NDC 0456-3414-63) Product currently unavailable; estimated duration 1 year Manufacturing delay based upon commercial stability data and the discontinuation of blister packaging. Other
Namenda XR 21 mg Bottle of 30 (NDC 0456-3421-33) Product currently available in limited supply; estimated duration 4-6 months Manufacturing delay based upon commercial stability data and the discontinuation of blister packaging. Other
Namenda XR 28 mg Bottle of 30 (NDC 0456-3428-33) Product currently available in limited supply; estimated duration 4-6 months Manufacturing delay based upon commercial stability data and the discontinuation of blister packaging. Other
Namenda XR 28 mg 10 x 10 Unit Dose (NDC 0456-3428-63) Product currently unavailable; estimated duration 1 year Manufacturing delay based upon commercial stability data and the discontinuation of blister packaging. Other
Namenda XR Titration Pack: Contains 28 capsules (7 x 7 mg, 7 x 14 mg, 7 x 21 mg, 7 x 28 mg) (NDC 0456-3400-29) Product currently unavailable; estimated duration 1 year Manufacturing delay based upon commercial stability data and the discontinuation of blister packaging. Other
Namenda XR 28 mg Bottle of 90 (NDC 0456-3428-90) Product currently unavailable; estimated duration 6-12 months Manufacturing delay based upon commercial stability data and the discontinuation of blister packaging. Other
-
-